Effect of Total Meal Replacement Program Compared with a Reduced-Energy Food-Based Diet Plan on Glycemic Status—Results from the OPTIWIN Study

J. Loper,Seletha Periman,Sally L. Coburn,L. Matarese,A. Rothberg,W. Pories,K. Lewis,Anthony Auriemma,J. Ard
DOI: https://doi.org/10.2337/DB18-298-LB
IF: 7.7
2018-06-22
Diabetes
Abstract:Background: Weight loss can resolve dysglycemia. We wanted to know whether total meal replacement (TMR) was more effective compared to a reduced-energy food based diet. Methods: We conducted a 52-week multicenter, open-label RCT in adults with a BMI of 30-55 kg/m2. Participants (n=330) were randomized to the OPTIFAST Program (OP), a TMR diet (800-980 kcal/day) with behavioral intervention, or to a reduced-energy (-500 to -750 kcal/day) food-based diet with behavioral intervention (FB) based on the Diabetes Prevention Program. In this analysis, we studied the impact of the OP on changes in the prevalence of PREDM and DM from baseline to 26 and 52 weeks compared to FB. Endpoints were analyzed using a modified intent to treat approach, including all randomized participants who initiated treatment with at least one follow-up weight measure (n=273; 82.7%). Missing data were imputed using last observation carried forward. Statistical analysis was performed using SAS Version 9.3. Results: Results are shown below. OP participants lost more weight and had greater improvement in HbA1c than FB. Diabetes remitted more in OP than in FB in observed cases at 26 weeks. Prediabetes prevalence decreased similarly in both groups. Conclusions: Total meal replacement (OPTIFAST program) led to greater weight loss and had a significant impact on glycemia in participants with DM and PREDM. Disclosure A.E. Rothberg: Other Relationship; Spouse/Partner; Merck & Co., Inc.. Consultant; Spouse/Partner; Janssen Pharmaceuticals, Inc. J.D. Ard: Consultant; Self; Nestle. Research Support; Self; Nestle, VIVUS, Inc. A. Auriemma: Speaker9s Bureau; Self; Novo Nordisk Inc. S.L. Coburn: Other Relationship; Self; Nestle. K.H. Lewis: Research Support; Self; Nestle. J. Loper: None. L.E. Matarese: Research Support; Self; Nestle, Abbott. S. Periman: Employee; Self; Nestle. W.J. Pories: None.
Biology,Medicine
What problem does this paper attempt to address?